KATELYN PERRY: Open Payments
NPI 1750017794 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 10 payments from 6 companies in 2025. Trend: 2023 $175 · 2024 $260 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Boston Scientific Corporation | 1 | $14 |
Products named: VRAYLAR, QULIPTA, JARDIANCE, SAPIEN 3 Ultra RESILIA, M-M-R II, SPRAVATO, GARDASIL 9, WaveWriter Alpha Prime 16.
Industry payments across UT — which companies pay providers there.
